Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-051041

Director acquired 6,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ajer Jeffrey Robert Director 2019-09-25 Grant or award +6,500 24,750 D
Derivatives
Ajer Jeffrey Robert Director 2019-09-25 Grant or award · Stock Option +13,000 13,000 D
Loading xslF345X03/doc4.xml…